Hutchison China MediTech Ltd ADR Stock
The Hutchison China MediTech Ltd ADR stock is trending slightly upwards today, with an increase of €0.050 (0.510%) compared to yesterday's price.
Currently there is a rather positive sentiment for Hutchison China MediTech Ltd ADR with 5 Buy predictions and 1 Sell predictions.
As a result the target price of 16 € shows a very positive potential of 62.44% compared to the current price of 9.85 € for Hutchison China MediTech Ltd ADR.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 0.510% | 2.604% | 2.604% | -32.993% | -9.633% | -31.119% | -72.017% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -5.172% | 0.917% | -45.813% | -55.645% |
| China Resources Pharmaceutical Group Ltd | 0.000% | -1.869% | 8.025% | -7.080% | 10.294% | -23.358% | 20.413% |
| Repligen Corp. | 3.890% | 11.210% | 12.439% | 37.194% | -2.449% | -11.923% | -36.212% |
Comments
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $20.00 to $17.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $21.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat